COGNIZANT CAPITAL: Financing the Decade Ahead
Nearly all the value is past the horizon.
Over the past two years, the talk of the town has shifted from $10 billion valuations to $100 billion buildouts. Training clusters are sized in gigawatts. Launch is priced by the ton. The interesting companies no longer look like software — they have fleets, contracts, power constraints and depreciation schedules — and by the end of the decade they will be the largest industrial concerns on earth.
The buildout has begun. The capital has noticed; the underwriting has not caught up. A generalist investor prices these businesses off last cycle's multiples and arrives at a number that is either absurdly high or absurdly low, and usually cannot tell which. Meanwhile the founders building them are told to run their own raise between board meetings, with a template deck and a warm-intro spreadsheet.
Everyone is now talking about AI and space. Remarkably few have read a depreciation schedule for either. The whole value of a frontier company sits beyond the explicit forecast period — in the terminal — and the number of investors who can genuinely underwrite that is small, specific, and not on any list you can buy.
Cognizant Capital is a capital advisory firm for these companies. Two partners, both former investment bankers. We build the investment case, map the capital, and run the raise end to end — the way a sell-side process is run, because a company only goes to market once. Two sectors. Three mandates at a time. We decline everything else.
Let us tell you what we see.
Table of Contents
Each page stands on its own, though we would encourage reading them in order.
Introduction [this page]
The value is past the horizon, and the underwriting has not caught up.
I. The Thesis
A raise is a process, and processes can be run properly. Diagnostic, investment
case, the map of capital, a banked timetable, terms. What we will not do, and how
we are paid, stated plainly.
II. The Sectors
Artificial intelligence and space — two markets where the money is real and
the underwriting is hard. Capex is not a flaw in the story; it is the story.
III. Case Studies
Two raises, both closed, both still clients. A Series A rebuilt around a contracted
backlog, and a growth round cut in half by financing the hardware against itself.
IVa. The Terminal Is the Whole Company
Standard venture underwriting quietly assumes the explicit forecast period carries
meaningful value. For capital-intensive frontier businesses it carries almost none
— and everything about how you raise should change as a result.
IVb. What Kills a Frontier Raise
Eight failure modes, drawn from processes we have run and many more we watched from
the other side of the table. None of them are the technology.
V. The Firm
Two ex-bankers who kept getting asked the same favour. Small on purpose, honest
about being early, and not a fund — we have no allocation to defend.
Investor Access
Data-room access for active counterparties; deal-flow registration for investors in
AI and space.
Enquiries
Raising in the next two quarters? The most useful conversation happens before the
deck exists.
Next: I. The Thesis
Nothing on this site is an offer to sell or a solicitation of an offer to buy any security, or investment advice. Entity and regulatory details to be confirmed with counsel before publication. Partner names, case studies and figures are placeholders in this draft.
Dedicated to the ones building past the horizon.